Long Term Safety Study Of Amifampridine Phosphate In Patients With Musk Antibody Positive And Achr Antibody Positive Myasthenia Gravis Patients
Posted Date: May 15, 2019
- Investigator: Hani Kushlaf
- Type of Study: Drug
MuSK (MSK-003 OL)
Criteria:
? Must Be At Least 18 Years Of Age ? Must Have Participated In A Previous Study With The Study Med
Keywords:
Achr Antibody Positi, Musk Antibody Positi, Myasthenia Gravis
For More Information:
Molly Winters
513-558-0269
molly.winters@uc.edu